SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.

Andere Sprachen Shanghai Shyndec Pharmaceutical Co., Ltd.

Aktien

A0M4PZ

CNE000001JG2

600420

Pharmazeutika

Schlusskurs Shanghai S.E. Andere Börsenplätze 19.06.2025			% 5 Tage	% 1. Jan.
10.47 ^CNY	-1.04%		-4.82%	-12.31%

05.06.	Zwei Medikamente von Shyndec Pharmaceutical bestehen behördliche Bewertung	MT
05.06.	Shyndec Pharma erhält Zulassungsbescheinigung für Bluthochdruckmedikament	MT

Andere Sprachen

Shyndec Pharmaceutical's Two Drugs Pass Regulatory Evaluation	05.06.
Shyndec Pharma Gets Registration Certificate for Hypertension Drug	05.06.
Shanghai Shyndec Pharmaceutical Gets Approval for Anti-Tumor Injection	29.05.
Shyndec Pharmaceutical Unit's Amikacin Sulfate Injection Passes Regulatory Consistency Evaluation	14.05.
Shanghai Shyndec Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	28.04.
Shyndec Pharmaceutical Passes Consistency Evaluation for Antibiotic Drug	16.04.
Shanghai Shyndec Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	27.03.
Shyndec Pharmaceutical Subsidiary Passes Generic Drug Consistency Evaluation for Asthma Drug	18.03.
Shyndec Pharmaceutical's Unit Gets Registration Certificate for Methylprednisolone Tablets	17.03.
Shyndec Pharmaceutical Obtains Registration Certificates for Antiviral, Anticoagulant Drugs	11.03.
Shanghai Shyndec Pharmaceutical's Pravastatin Sodium Tablets Passes Chinese Drug Regulator's Consistency Evaluation	04.03.
Shyndec Pharma's Units Get Three Drug Registration Certificates	22.01.
Shanghai Shyndec's Shenzhen Unit Passes EU GMP Inspection	20.01.
Shyndec Pharma Unit's Cefuroxime Sodium for Injection Passes Regulatory Consistency Evaluation	20.01.
Shyndec Pharma Gets China Pharmaceutical Ingredient Approval for Anaesthesia Supplementary Drug	08.01.
Chinese Drug Regulator Denies Marketing of Shyndec Pharmaceutical's UTI Treatment Drug	03.01.
Shanghai Shyndec Pharmaceutical Co., Ltd.(SHSE:600420) added to Shanghai Stock Exchange Health Care Sector Index	18.12.
Shanghai Shyndec Pharmaceutical Unit Gets China Nod for Antibiotic Ingredient	17.12.
Shyndec Pharmaceutical Unit Gets Nod to Register Cefpodoxime Proxetil Tablets	12.12.
Shyndec Pharma Unit's Codeine Phosphate Included in China's Listing of Chemical Raw Materials	06.12.
Shanghai Shyndec Pharmaceutical Gets Drug Registration for Eye Drops	03.12.
Shanghai Shyndec Pharmaceutical Passes Drug Evaluation for Calcium Gluconate Injection	27.11.
Shanghai Shyndec Pharmaceutical CFO Resigns	27.11.
Shanghai Shyndec Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	28.10.24
China Approves Shyndec Pharmaceutical's Listing Application for Epilepsy Drug Ingredient	05.09.24

Keine Ergebnisse zu dieser Suche

Mehr Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Shanghai Shyndec Pharmaceutical Co., Ltd.

Aktien

A0M4PZ

CNE000001JG2

600420

Pharmazeutika

Andere Sprachen

Filter